Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free LABS Stock Alerts

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.08 0.00 (0.00%)
As of 02:26 PM Eastern
Compare

LABS vs. MGW, I, TGOD, NINE, and IGX

Should you buy MediPharm Labs stock or one of its competitors? MediPharm Labs's main competitors and comparable companies include Maple Leaf Green World (MGW), Intellipharmaceutics International (I), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), and IntelGenx Technologies (IGX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does MediPharm Labs compare to Maple Leaf Green World?

MediPharm Labs (TSE:LABS) and Maple Leaf Green World (CVE:MGW) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Maple Leaf Green World has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Maple Leaf Green World's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
Maple Leaf Green World N/A N/A N/A

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, MediPharm Labs had 4 more articles in the media than Maple Leaf Green World. MarketBeat recorded 4 mentions for MediPharm Labs and 0 mentions for Maple Leaf Green World. MediPharm Labs' average media sentiment score of 0.62 beat Maple Leaf Green World's score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the media.

Company Overall Sentiment
MediPharm Labs Positive
Maple Leaf Green World Neutral

Maple Leaf Green World has lower revenue, but higher earnings than MediPharm Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A
Maple Leaf Green WorldN/AN/AN/AN/AN/A

Summary

MediPharm Labs beats Maple Leaf Green World on 5 of the 8 factors compared between the two stocks.

How does MediPharm Labs compare to Intellipharmaceutics International?

MediPharm Labs (TSE:LABS) and Intellipharmaceutics International (TSE:I) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Intellipharmaceutics International has lower revenue, but higher earnings than MediPharm Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A
Intellipharmaceutics InternationalN/AN/AN/AN/AN/A

In the previous week, MediPharm Labs had 4 more articles in the media than Intellipharmaceutics International. MarketBeat recorded 4 mentions for MediPharm Labs and 0 mentions for Intellipharmaceutics International. MediPharm Labs' average media sentiment score of 0.62 beat Intellipharmaceutics International's score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the media.

Company Overall Sentiment
MediPharm Labs Positive
Intellipharmaceutics International Neutral

0.3% of MediPharm Labs shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Intellipharmaceutics International has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Intellipharmaceutics International's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
Intellipharmaceutics International N/A N/A N/A

Summary

MediPharm Labs beats Intellipharmaceutics International on 5 of the 8 factors compared between the two stocks.

How does MediPharm Labs compare to Green Organic Dutchman?

Green Organic Dutchman (TSE:TGOD) and MediPharm Labs (TSE:LABS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

In the previous week, MediPharm Labs had 4 more articles in the media than Green Organic Dutchman. MarketBeat recorded 4 mentions for MediPharm Labs and 0 mentions for Green Organic Dutchman. MediPharm Labs' average media sentiment score of 0.62 beat Green Organic Dutchman's score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the news media.

Company Overall Sentiment
Green Organic Dutchman Neutral
MediPharm Labs Positive

MediPharm Labs has higher revenue and earnings than Green Organic Dutchman. MediPharm Labs is trading at a lower price-to-earnings ratio than Green Organic Dutchman, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Green Organic DutchmanC$31.37M0.00-C$137.58M-C$0.26N/A
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Green Organic Dutchman has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Green Organic Dutchman's return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Green Organic DutchmanN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

Summary

MediPharm Labs beats Green Organic Dutchman on 7 of the 11 factors compared between the two stocks.

How does MediPharm Labs compare to Delta 9 Cannabis?

Delta 9 Cannabis (CVE:NINE) and MediPharm Labs (TSE:LABS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Delta 9 Cannabis has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. Delta 9 Cannabis' return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Delta 9 CannabisN/A N/A N/A
MediPharm Labs -20.21%-23.55%-7.17%

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Delta 9 Cannabis has higher earnings, but lower revenue than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than Delta 9 Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$12.87M6.94C$4.69MC$0.0519.07
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A

In the previous week, MediPharm Labs had 4 more articles in the media than Delta 9 Cannabis. MarketBeat recorded 4 mentions for MediPharm Labs and 0 mentions for Delta 9 Cannabis. MediPharm Labs' average media sentiment score of 0.62 beat Delta 9 Cannabis' score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the news media.

Company Overall Sentiment
Delta 9 Cannabis Neutral
MediPharm Labs Positive

Summary

Delta 9 Cannabis beats MediPharm Labs on 7 of the 12 factors compared between the two stocks.

How does MediPharm Labs compare to IntelGenx Technologies?

MediPharm Labs (TSE:LABS) and IntelGenx Technologies (CVE:IGX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

0.3% of MediPharm Labs shares are owned by institutional investors. 4.5% of MediPharm Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

IntelGenx Technologies has lower revenue, but higher earnings than MediPharm Labs. IntelGenx Technologies is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$43.28M0.74-C$12.05M-C$0.02N/A
IntelGenx TechnologiesC$1.75M49.95-C$11.74M-C$0.08N/A

In the previous week, MediPharm Labs had 4 more articles in the media than IntelGenx Technologies. MarketBeat recorded 4 mentions for MediPharm Labs and 0 mentions for IntelGenx Technologies. MediPharm Labs' average media sentiment score of 0.62 beat IntelGenx Technologies' score of 0.00 indicating that MediPharm Labs is being referred to more favorably in the media.

Company Overall Sentiment
MediPharm Labs Positive
IntelGenx Technologies Neutral

IntelGenx Technologies has a net margin of 0.00% compared to MediPharm Labs' net margin of -20.21%. IntelGenx Technologies' return on equity of 0.00% beat MediPharm Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-20.21% -23.55% -7.17%
IntelGenx Technologies N/A N/A N/A

Summary

MediPharm Labs beats IntelGenx Technologies on 7 of the 12 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

Export
MetricMediPharm LabsPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$31.87MC$11.74BC$6.99BC$12.55B
Dividend YieldN/A2.70%2.58%6.20%
P/E Ratio-3.75781.46269.5530.69
Price / Sales0.74748.20597.759.73
Price / Cash1.3067.4570.5382.29
Price / Book0.9110.7613.084.64
Net Income-C$12.05MC$2.77BC$3.45BC$299.09M
7 Day PerformanceN/A0.05%1.02%0.91%
1 Month PerformanceN/A0.20%1.68%3.87%
1 Year PerformanceN/A161.31%67.42%36.03%

MediPharm Labs Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.08
flat		N/A-16.7%C$31.87MC$43.28MN/A130
MGW
Maple Leaf Green World
N/AC$0.79
+777.8%		N/A+0.0%C$111.69MN/AN/AN/A
I
Intellipharmaceutics International
N/AN/AN/AN/AC$97.40MN/AN/A1,069
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37MN/A41
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%		N/A+0.0%C$89.36MC$12.87M19.07940

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:LABS) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Why I'm sending this one to my own family
Behind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...
Behind the Markets | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel